CURRICULUM VITAE
September 2009
Business Address: 921 Salk Hall
University of Pittsburgh
Pittsburgh, PA 15261
Phone: (412) 624-6715; Fax: (412) 624-1850
E-mail: coley@pitt.edu
Licensure: Pennsylvania
APPOINTMENTS
Academic
2009 - Professor
Department of Pharmacy and Therapeutics
University of Pittsbugh School of Pharmacy
1999 - 2009 Associate Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh, School of Pharmacy
1990 - 1999 Assistant Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh, School of Pharmacy
1989 - 1990 Clinical Instructor
Department of Pharmacy Practice
Philadelphia College of Pharmacy and Science
1987 - 1989 Teaching Assistant
Department of Pharmacy Practice
Philadelphia College of Pharmacy and Science
Other
2001 – present Director, Center for Pharmacoinformatics and Outcomes Research
University of Pittsburgh School of Pharmacy
2004 – 2005 Interim Director, Drug Information Residency Program
University of Pittsburgh Medical Center
1995 - 2000 Program Coordinator, Pharmacoepidemiology Research Program
Center for Clinical Pharmacology
University of Pittsburgh Medical Center
1990 -1995 Drug Information Specialist
Drug Information and Pharmacoepidemiology Center
University of Pittsburgh Medical Center
1991 - 1995 Residency Program Coordinator
Specialized Residency in Drug Information (ASHP accredited)
University of Pittsburgh School of Pharmacy
EDUCATION
1989 - 1990 Advanced Residency in Drug Information
Thomas Jefferson University Hospital, Philadelphia, PA 19107
1987 - 1989 Doctor of Pharmacy
Philadelphia College of Pharmacy and Science, Philadelphia, PA 19104
1982 - 1987 Bachelor of Science in Pharmacy, Cum Laude
University of Pittsburgh, Pittsburgh, PA 15260
TRAINING and CONTINUING EDUCATION
May 2002 Decision Analysis: Advanced Applications. ISPOR Short Course
June 2001 Measurement, Design, and Analysis Methods for Health Outcomes Research
Harvard Graduate School of Public Health
July 2000 Summer Research Institute in Geriatric Psychiatry
NIMH and American Association of Geriatric Psychiatry
Fall 1998 Cost-Effectiveness Analysis Course
University of Pittsburgh Graduate School of Public Health
Spring 1996 UNIX and GNU EMACS Short Courses
University of Pittsburgh Computing & Information Services
Sept 1994 Outcomes and Pharmacoeconomics in Pharmaceutical Care
ASHP and the New England Medical Center
PROFESSIONAL EXPERIENCE
1995 - 1997 Freelance Scientific Writer, Scientific Connexions
Yardley, PA 19067
1989 - 1990 Staff Pharmacist, Thomas Jefferson University Hospital
Philadelphia, PA 19107
1987 - 1989 Staff Pharmacist, Hospital of the University of Pennsylvania
Philadelphia, PA 19104
HONORS AND AWARDS
2008 University of Pittsburgh Women in Science and Medicine
2008 Faculty Honoree, University of Pittsburgh Honors Convocation
2007 Fellow, American College of Clinical Pharmacy
2004 Who’s Who in Pharmaceutical Sciences Education
1997 Full Member, American College of Clinical Pharmacy
1995 Hole-in-one, North Park Golf Course, Pittsburgh, PA
1987 Cum Laude, B.S. Pharmacy, University of Pittsburgh
1987 Upjohn Achievement Award
1986 University of Pittsburgh Alumni Leadership Certificate
1986 Rho Chi Pharmaceutical Honor Society
1986 Scott Horton Memorial Scholarship
PROFESSIONAL ORGANIZATIONS
2005 - 2008 American Heart Association
2001 - 2008 American Association of Geriatric Psychiatry
1995 - 2008 American Pharmaceutical Association
1995 - present International Society for Pharmacoeconomics and Outcomes Research
1990 - present American College of Clinical Pharmacy
1990 - 2000 UHC Drug Information Network
1985 - present American Society of Hospital Pharmacists
1984 - present Lambda Kappa Sigma Pharmaceutical Fraternity
1991 - 1997 Drug Information Association
1990 - 1997 Western Pennsylvania Society of Hospital Pharmacists
1990 - 1996 Drug Information Specialty Practice Group
1990 - 1996 American Association of Colleges of Pharmacy
1987 - 1990 Delaware Valley Society of Hospital Pharmacists
1985 - 1997 Pennsylvania Society of Hospital Pharmacists
1984 - 1989 Pennsylvania Pharmaceutical Association
1984 - 1989 American Pharmaceutical Association
TEACHING RESPONSIBILITIES
Graduate/Professional
2008 - present Pharmacy 5210; Experiential Learning (Nonprescription Therapy and Self Care)
2006 - present Pharmacy 5225; Advanced Pharmaceutical Care
2005 - present Pharmacy 5311, Health Outcomes and Pharmacoeconomics
2000 - 2004 Pharmacy 5311, Health Outcomes and Pharmacoeconomics (Course Coordinator)
1999 - 2006 Epidemiology 2850; Introduction to Pharmacoepidemiology
1996 - present Medicine; Integrated Life Sciences Selective: Pharmacoeconomics
1996 - 1999 Pharmacy, Doctor of Pharmacy Clerkship
1992 - 1998 Pharmacy 3403; Doctor of Pharmacy Seminar I, Course coordinator
1992 - 1998 Pharmacy 3406; Doctor of Pharmacy Seminar II, Course coordinator
1992 - 1999 Pharmacy 3416; Doctor of Pharmacy Seminar III, Course coordinator
1992 - 1999 Pharmacy 3420; Doctor of Pharmacy Seminar IV, Course coordinator
1992 - 1996 Pharmacy 3401/3421; Advanced Pharmacotherapy
1992 - 1995 Pharmacy 3410; Doctor of Pharmacy Clerkship
Undergraduate/Professional
1999 - 2001 Experiential Learning
1999 - 2000 Pharmacy 5400, PharmD Seminar (Course Coordinator)
1998 - 2000 Pharmacy 5212, Experiential Learning 3
1998 - 1999 Pharmacy 5201, Pharm 5211; Profession of Pharmacy 4
1997 - 1999 Pharmacy 5210; Profession of Pharmacy 3
1996 - 1998 Pharmacy 5110; Profession of Pharmacy 1, Co-coordinator – professional inquiry
1990 - 1995 Pharmacy 1400; Drug Information and Literature Evaluation
1991 - 1992 Pharmacy 1510; Pharmacy Externship
1990 - 1993 Pharmacy 1500; Clinical Pharmacy Clerkship
1993 - 1997 Pharmacy 1601; Professional Development
Residency Program
2004 – present Resident Research Series
2004 - 2005 Drug Information Residency Program Director (Interim)
1996 - present Preceptor, Health Outcomes Research Rotation
1991 - 1995 Drug Information Residency Program Coordinator, Residency Preceptor
1991 - 1995 Preceptor for Drug Information, Pharmacy Practice Residency
Post-Doctoral Drug Information Residency Training
1991-1992 John Schlict, Pharm.D., MBA
1992-1993 Michael Kendrach, Pharm.D.
1993-1994 Lidia Gajewski, Pharm.D.
1994-1995 Ushma Mehta, Pharm.D.
1994-1995 Michelle McCarthy, Pharm.D.
2004-2005 Suzanna Gim, Pharm.D.
Outcomes Research Fellowship Program - Director
2005 - 2007 Tina Scipio, Pharm.D.
2003 - 2005 Mallik V. Angalakuditi, Ph.D.
COMMITTEE and PANEL APPOINTMENTS
University of Pittsburgh Medical Center
1991-2004 Pharmacy and Therapeutics Committee
1996 - present WPIC (Psychiatry) Pharmacy and Therapeutics Subcommittee
1996-1998 Drug Use and Disease State Management Committee
1994-1995 Therapeutic Evaluation and Modification (TEAM) Subcommittee
1994-1995 Formulary Subcommittee
1994 Drug Expense Reduction Task Force
1994 Clinical Services Task Force
1993; 1994 Drug Information Specialist Search Committee
1992-1995 Drug Advisory Program Steering Committee
1991-1995 Antibiotic Subcommittee
1990-1991 Drug Usage Evaluation Subcommittee
University of Pittsburgh
2007 University of Pittsburgh Institute on Aging, Research Review Committee
2006; 2007 Competitive Medical Research Fund (CMRF), Review Committee
2006 Thesis Review Committee, Dr. Sherrie Aspinall, Pharm.D., MSc.
2006 - 2008 University of Pittsburgh Senate Council
2005 - 2008 University of Pittsburgh Faculty Assembly
2004 - present University of Pittsburgh Institutional Review Board (ad hoc member)
2007 - 2009 Commonwealth Relations Committee, University of Pittsburgh Senate, Member
2003 - 2007 Commonwealth Relations Committee, University of Pittsburgh Senate, Pro-Tem
2003 Dean Search Committee, University of Pittsburgh School of Pharmacy
2000 - 2004 University of Pittsburgh Institutional Review Board
2000 - 2006 University of Pittsburgh Council on Aging
University of Pittsburgh School of Pharmacy
2008 - present Admissions Committee, Chair
2007 - present Residency and Fellowship Council
2007 - 2008 ACPE Self-Study Committee
2007 - present Promotion and Tenure Committee
2007 Search Committee, Vice Chair for Clinical Sciences Research
2006 Promotion and Tenure Process Improvement Task Force
2004 – present Annual SOP Golf Invitational Committee
2004 - 2005 WPIC Pharmacy Director Search Committee, Chair
2004 Promotion Committee, Mr. Robert Weber
2003 - 2007 Residency Committee, Chair
2002 Promotion Committee, Dr. Levent Kirisci
2002 - 2004 Planning and Budgeting Committee
2002 Department Executive Committee
2002 - 2003 School of Pharmacy Residency Committee
2001 - 2002 Promotion and Tenure Committee
2001; 2002 Outcomes Research Faculty Search Committee, Chair
2000 Nutrition Support Specialist Search Committee
1994; 2000 Drug Information Specialist Search Committee
2000 Population Pharmacokinetics Search Committee
1998 Pharmacy Administration Search Committee
1997- 2002 Curriculum Committee
1995-1996 P1 Planning Committee
1994-1996 Department of Pharmacy and Therapeutics Executive Committee
1992-1995 Pharmacy Residency Committee
1992-1995 Doctor of Pharmacy Clerkship Committee
1992-1993 Pharmaceutical Sciences Search Committee
1990-1991 Academic Integrity Committee
National or Regional
2007 ASHP Medication Continuity of Care Record Expert Panel
2007 ASHP Continuity of Care - Personal Medication Record Expert Panel
2007 Chair, 2009 ACCP Annual Meeting Program Committee
2007 ASHP Foundation Junior Investigator Grant Program Review Panel
2007 ISPOR Research Excellence Award Task Force
2006 - 2007 ISPOR Fellowship Standards Task Force
2006 - 2007 ACCP Publications Committee
2006 ASHP Research Foundation Grants Review Panel
2006 - 2007 AHA Contributed Research Abstract Review Committee
2006; 2007 ISPOR Contributed Research Abstract Review Committee
2005 - 2007 AHA – Annual QCOR Scientific Forum Program Planning Committee
2005 ACCP 2005 Health Outcomes Investigator Development Research Award Panel
2004 - 2005 ISPOR Research Excellence Awards Task Force
2003 - 2007 ASHP Foundation Literature Awards Selection Panel
2003 - 2005 AHA, Steering Committee for Quality of Care and Outcomes Research
in Cardiovascular Disease and Stroke
2001 - 2002 Zyprexa® Pharmacy Advisory Board, Eli Lilly
1995 - 1999 PACE Western Pennsylvania Regional DUR Advisory Committee
1994 Express Pharmacy Services Medical Advisory Board, Consultant
STUDENT/RESIDENT ACTIVITIES
2003 - present Faculty Research Mentor, Resident Research Series
1994 Presentation Moderator/Evaluator, Eastern States Conference for
Pharmacy Residents and Preceptors
1993 - present Faculty Advisor, University of Pittsburgh School of Pharmacy
1993 - 1994 Co-Advisor, University of Pittsburgh Academy of Students of Pharmacy
1992 - 1999 Faculty Advisor, Doctor of Pharmacy Program, U.of Pitt. Pharmacy School
1992 Faculty Advisor, Pitt Pharmacy Student Leadership Conference
SCIENTIFIC & EDITORIAL ACTIVITIES
2008 Journal of Pharmacy Teaching. Reviewer.
2007 Value in Health. Reviewer.
2007 - present Pharmacotherapy. Reviewer.
2006 Bipolar Disorders. Reviewer.
2004 - present American Journal of Health-System Pharmacy. Reviewer.
2004 American Journal of Geriatric Pharmacotherapy. Reviewer.
2004; 2007 American Journal of Geriatric Psychiatry. Reviewer.
2003 Neuro-Psychopharmacology & Biologic Psychiatry. Reviewer.
2003 Journal of the American Geriatrics Society. Reviewer.
2002; 2006 Epilepsia. Reviewer.
2002 International Journal of Geriatric Psychiatry. Reviewer.
2002 - 2007 Mosby’s DRUG Consult. Editorial Board.
2000 - 2003 Journal of the American Pharmaceutical Association, Editorial Advisory Board
2000 - present Journal of the American Pharmaceutical Association, Reviewer.
1999 - present WPIC (Psychiatry) Research Committee. Research Protocol Reviewer.
1997, 2000, 2003 Pharmacology and the Nursing Process. Chapter Reviewer.
1995 - 2001 Physicians GenRx. Editorial Review Panel.
1995, 1999, 2001 Handbook of Nonprescription Drugs. Reviewer.
1994 Pharmacotherapy. Reviewer.
1993 - 2002 Formulary. Reviewer.
1991 - 1997 Journal of the American Pharmaceutical Association, Reviewer
1990 - 1995 Pharmacy Consult. University of Pittsburgh, Drug Information and
Pharmacoepidemiology Center; Editorial Board; Managing Editor.
1990 - 2000 Drugdex® Drug Information System. Contributing Author; Editor.
1992 - 2000 UHC Drug Monographs. Contributing Reviewer.
1989 - 1990 Pharmacy Newsletter. Thomas Jefferson University Hospital; Co-editor.
1989 - 1990 Drug Information News Update. Thomas Jefferson Univ. Hosp; Editor.
PUBLICATIONS
Students/residents/fellows* under my direction are indicated by an asterisk.
Peer Reviewed Manuscripts:
1. Coccodrilli KR. Home testing products. American Druggist 1989;200(5):79-85.
2. Coccodrilli KR. Multiple-dose vial expiration. Hospital Therapy 1989;14(12):26-29.
3. Coccodrilli KR. The use of clomipramine in the treatment of trichotillomania. P&T 1990;15(9):1125-1126.
4. Coccodrilli KR. Therapeutic use of lidocaine plus sodium bicarbonate for percutaneous infiltration. P&T 1990;16(8):1015-1019.
5. Coley KC. Contraception: what pharmacists should tell their patients. Am Pharm 1993;NS33(9):55-66.
6. Schlicht JR*, Markind JE, Vanscoy GJ, Coccodrilli KR. Quinolone antibiotics. P&T 1993;18(3):280-90.
7. McCarthy M*, Coley KC. Aprotinin for prophylaxis of blood loss. Ann Pharmacother 1994;28(11):1246-8.
8. Carter CS, Mulsant BH, Sweet RA, Maxwell R, Coley K, Ganguli R, Branch R. Risperidone use in a teaching hospital during its first year after market approval: economic and clinical implications. Psychopharm Bull 1995;31(4):719-25.
9. Coley KC, Crain JL. Miconazole-induced fatal dysrhythmia. Pharmacotherapy. 1997;17(2):379-82.
10. Kazmierczak R*, Coley KC. The impact of product labeling changes on prescribing: evaluation of the use of tramadol HCl (Ultramâ). Formulary 1997;32(9):968-78.
11. Coley KC, DaPos SV, Saul MI, Branch RA. Outcomes assessment in routine practice: Use of an electronic medical records database. Formulary 1999;34(1):52-7.
12. Coley KC, Carter CS, DaPos SV, Maxwell R, Wilson JW, Branch RA. Effectivness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol. J Clin Psych 1999;60(12):850-56.
13. Coley KC, Skledar SJ, Fine MF, Yealy DM, Gleason PP, Ryan ML, Kapoor W, Branch RA. Changing physician prescribing behavior: the community-acquired pneumonia trial. Am J Health-Syst Pharm 2000;57(16):1506-10.
14. Coley KC, Verrico MM, McNamara DM, Park SC, Cressman MD, Branch RA. Lack of tacrolimus-induced cardiomyopathy. Ann Pharmacother 2001;35(9):985-989.
15. Conley EL*, Coley KC, Pollock BG, DaPos SV, Maxwell R, Branch RA. Valproic Acid and thrombocytopenia: experience at a psychiatric teaching hospital. Pharmacotherapy 2001;21(11):1325-1330.
16. Calabrese AT*, Coley KC, DaPos SV, Swanson D, Rao RH. Risk of lactic acidosis with metformin: an evaluation of prescribing practices. Arch Intern Med 2002.162;434-437.
17. Coley KC, Dapos SV, Williams BA, Chen C, Smith RB. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth. 2002 (14):349-53.
18. Bies RR, Gastonguay M, Coley KC, Kroboth PD, Dew MA, Pollock BG. Evaluating the consistency of pharmacotherapy exposure in observational trial designs. Am J Geriatr Psychiatry 2002;10:696-705.
19. Linden PK, Coley K, Fontes P, Fung JJ, Kusne S. Invasive aspergillosis in liver transplantation recipients: Outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. Clin Infect Dis. 2003 Jul 1;37(1):17-25.
20. Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D. Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa. Clin Infect Dis. 2003;37(11):e154-60.
21. Williams BA, Kentor ML, Vogt MT, Vogt WB, Coley KC, Williams JP, Roberts MS, Chelly JE, Harner CD, Fu FH. Economics of Nerve Block Pain Management after Anterior Cruciate Ligament Reconstruction: Hospital Cost Savings via Associated Postanesthesia Care Unit Bypass and Same-day Discharge. Anesthesiology. 2004. 100(3):697-706.
22. Steinmetz KL, Coley KC, Pollock BG: Assessment of geriatric information in the drug label for commonly prescribed drugs in the elderly. J Am Geriatr Soc. 2005;53(5):891-4.
23. Coley KC. Aripiprazole Use and Continuation Rates During Psychiatric Hospitalization. Ann Pharmacother 2005;39:1367-8.
24. Angalakuditi M*, Coley KC, Krenzelok E. Children’s acetaminophen exposures reported to a regional poison control center. Am J Health-Syst Pharm 2006;63:323-6.
25. Coley KC, Pringle JP, Weber RJ, Rice K, Ramanujam R, Sirio C. Perceived barriers in using a region-wide medication error reporting system. J Patient Saf 2006;2(1):39-44.
26. Corman SL*, Coley KC, Schonder KE. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients. Pharmacotherapy 2006.26(10):1433-7.
27. Angalakuditi M*, Coley KC, Kirisci L, Saul MI, Painter L. Association between in-hospital falls and chronic disease, drug use, and anemia: A matched case-control study. J Patient Saf 2007;3:16-21.
28. Coley KC, Saul MI, Seybert A. Economic burden of not recognizing panic disorder in the emergency department. J Emerg Med. 2009; 36(1):3-7.
29. Angalakuditi M*, Coley KC. Impact of drug use and comorbidities on in-hospital falls in patients with chronic kidney disease. Ann Pharmacother 2007;41:1638-43.
30. Bigos K, Pollock BG, Coley KC, Marder SR, Miller D, Bies RR. Sex, race and smoking impact olanzapine exposure. J Clin Pharmacol 2008;48:157-65.
31. Feng Y, Pollock BG, Coley K, Marder SR, Miller D, Kirshner M, Aravagiri M, Schneider L, Bies RR. Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements form the CATIE study. Br. J Pharmacol. 2008;66(5):629-39.
32. Coley KC, Fabian T, Kim E, Scipio T*, Ammerman DK, Saul M, Whitehead R, Ganguli R. Predictors of Aripiprazole Treatment Continuation in Hospitalized Patients. J Clin Psychiatry. 2008;69(9):1393-7.
33. Coley KC, Scipio TM*, Fabian TJ, Scelsi-Ruby C, Lenze EJ. Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients. J Psychiatric Practice. 2009;15(2):150-3.
34. Palkovic LB*, Sokos DR, Coley KC. Evaluation of clinical characteristics as predictors for the inappropriate prescribing of acid suppressive therapy in internal medicine inpatients. Int J Pharm Pract. 2009; 17(1):73-75.
35. Jin Y, Pollock BG, Coley K, Miller D, Marder S, Florian J, Schneider L, Lieberman J, Kirshner M, Bies RR. Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: Impact of race and smoking. J Clin Pharmacology. June 2009. Accepted.
Abstracts at Professional and Scientific Meetings:
1. Stablein AM, Vanscoy GJ, Coccodrilli KR, Schlicht JR. Drug information internship: valuable cognitive training for tomorrow's pharmacist. ASHP Midyear Clinical Meeting. 1991;26.
2. Vanscoy GJ, Coccodrilli KR, Stoehr GP. A student-centered approach for teaching drug information and literature evaluation. Am J Pharm Ed 1991;55:140S.
3. Coccodrilli KR, Markind JE, Vanscoy GJ. Design and implementation of a multi-hospital staff development program in drug information at a university medical center. ASHP Midyear Clinical Meeting. 27:DIRF-6. Dec 1992.
4. Coley KC, Kendrach MG, Vanscoy GJ. Residency Portfolio: a tool for self-directed development. ASHP Midyear Clinical Meeting. 28:P-120D. Dec 1993.
5. Coley KC, Branch RA, Carter CS. Market penetration of newly approved drugs: the risperidone experience. Pharmacotherapy 1996;16(3):510.
6. Coley KC, Verrico MM, McNamara DM, Park SC, Cressman MD, Branch RA. Tacrolimus-induced cardiomyopathy: a systematic review of over 3600 adult patients. J Amer Coll Cardiol 1998;31(2):149A.
7. Linden P, Coley K, Kramer D. Kusne S, Fung J. Patterns of CMV antigenemia and disease in CMV-seronegative liver recipients treated with preemptive ganciclovir. Transplantation 1999;67(7):S232.
8. Linden P, Coley K, Kramer D, Kusne S, Fung J. Invasive aspergillosis in liver transplant recipients: comparison of outcome with amphotericin B lipid complex and conventional amphotericin B. Transplantation 1999;67(7):S127.
9. Conley EL, Coley KC, DaPos SV, Maxwell R, Branch RA. Valproic Acid and thrombocytopenia: experience at a psychiatric teaching hospital. ASHP 34th Annual Midyear Clinical Meeting, Orlando, FL, Dec 1999.
10. Coley KC, Zak MB, Branch RA. Evaluation of the outcomes of hemodialysis patients receiving amphotericin B lipid complex (ABLC). Value in Health 1999; 2(3):185.
11. Calabrese AT, Coley KC, DaPos SV, Swanson D. Risk of lactic acidosis with metformin: an evaluation of prescribing practices. Diabetes 2000;49(Suppl 1):A100.
12. Coley KC, DaPos SV, Pollock BG. Treatment switches between atypical antipsychotics: a naturalistic evaluation of elderly inpatients. Am J Geriatr Psychiatry 2001;9(3 Suppl 1):58.
13. Bies RR, Coley KC, Kroboth PD, Pollock BG. Capturing drug exposures in large effectiveness trials. NCDEU, Phoenix, AZ. May 2001.
14. Coley KC, DaPos SV, Wilson JW, Carter CS. Comparative effectiveness of olanzapine, risperidone, and perphenazine in a naturalistic setting. NCDEU, Phoenix, AZ. May 2001.
15. Bies RR, Coley KC, Kroboth PD, Pollock BG. Application of Mixed Effects Modeling to Capturing Drug Clearance (CL) in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. AAPS Annual Meeting. Denver, CO. 2001.
16. Coley KC, DaPos SV, Williams BA, Chen C, Smith RB. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. Pharmacotherapy 2001;21(10):1285.
17. Seybert AL, Kane SL, Coley KC, Anderson WD, Smitherman TC. An analysis of pharmacoeconomic and therapeutic outcomes of abciximab and eptifibitide in patients undergoing percutaneous coronary intervention. 36th Annual ASHP Midyear Clinical Meeting. New Orleans, LA. 2001
18. Coley KC, Edmondston L, Pringle J. Relationship between substance abuse and treatment outcomes with the atypical antipsychotic agents. Pennsylvania Improvement Collaborative (PIC) Conference. Hershey, PA. July 2002.
19. Smith RB, Saul MI, Coley KC, ElZein H. Accuracy of using abbreviated MDRD equation to estimate GFR in possible CRI patients. J Am Soc Nephrol 2002;13(Suppl S):431A.
20. ElZein H, Coley KC, Saul MI, Smith RB. Laboratory Monitoring of Calcium, Phosphorus, and PTH in Patients with Chronic Renal Insufficiency. J Am Soc Nephrol 2002;13(Suppl S):623A.
21. Coley KC, Smith RB, Saul MI, ElZein H. Reliability of ICD-9-CM Coding for Chronic Renal Insufficiency. J Am Soc Nephrol 2002;13(Suppl S):431A.
22. Coley KC, Smith RB, Saul MI, ElZein H. Variability of Serum Creatinine Values in Patients with Stages 3, 4, and 5 Chronic Kidney Disease. J Am Soc Nephrol 2002;13(Suppl S):431A.
23. Bies RR, Gastonguay MR, Coley KC, Kroboth PD, Pollock BG. Measuring consistency of pharmacotherapy exposure in observational clinical trials using Cpred/Cobs ratio. AAPS Annual Meeting. Toronto. 2002.
24. Coley KC, Saul MI, Weisbord SD, Kim JJ, Pringle JL. Resource utilization trends among congestive heart failure patients with and without anemia. Circulation 2002; (16): P111.
25. Fedutes BA, Coley KC, Ansani NT, Maxwell R, Chengappa KN. An evaluation of the current prescribing trends for patients with bipolar disorder in a specialty hospital setting. ASHP Midyear Clinical Meeting. New Orleans, LA 2003;P-180D.
26. Coley KC, Robbins S, Smith RB: Prevalence of Anemia in Diabetic Patients With Chronic Kidney Disease in a Large Healthcare System. Diabetes 2004;53(Suppl 2):A239.
27. Coley KC, Saul MI, Kirisci L, Smith RB. Impact of Anemia on Hospitalization and Mortality in Elderly Patients with Chronic Obstructive Pulmonary Disease and Chronic Kidney Disease. Value in Health 2004;7(3):256.
28. Coley KC, Kirisci L, Saul MI, Robbins S, Smith RB: Association of Anemia with Adverse Outcomes in a Geriatric Population. American Society of Consultant Pharmacists 35th Annual Meeting. San Francisco, CA 2004.
29. Corman SC, Coley KC, Schonder KE. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients. Pharmacotherapy 2005;25(3):475.
30. Angalakuditi M, Rea R, Coley KC. Physician prescribing preferences in treating patients with presumed Pseudomonas aeruginosa pneumonia: mono- versus combination antibiotic therapy. Pharmacotherapy 2005;25(3):457.
31. Angalakuditi M, Coley KC, Kirisci L, Painter L. Impact of anemia on in-hospital falls: a matched case-control study. Value in Health 2005;8(3):281.
32. Angalakuditi M, Coley KC, Kirisci L, Painter L. Does anemia contribute to increased length of stay in patients experiencing in-hospital falls. Value in Health 2005;8(3):281.
33. Coley KC, Kirisci L, Saul MI, Robbins S, Smith RB. Anemia is associated with adverse outcomes in elderly patients with chronic heart failure. Circulation 2005;111(20):e340.
34. Angalakuditi M, Coley KC, Krenzelok EP. Description and comparison of pediatric acetaminophen exposures. ASHP MCM 2005;40:P10E.
35. Angalakuditi M, Coley KC, Kirisci L. Impact of anemia on length of stay in chronic kidney disease patients with in-hospital falls. ASHP MCM 2005;40:P434E.
36. Angalakuditi M, Coley KC, Kirisci L. Impact of anemia on in-hospital falls: A matched case-control study. ASHP MCM 2005;40:P404E.
37. Tortorici M, Skledar SJ, Coley KC. Evaluation of community acquired pneumonia patient readmission rates after pneumococcal polysaccarhide vaccine administration. ASHP MCM 2005;40:P541R.
38. Coley KC, Gim S, Weber RJ, Ganguli R. Changes in Novel Antipsychotic Use in Elderly Inpatients. Value in Health 2005;8(6):A201.
39. Gim S, Coley K, Weber RJ, Ganguli R. Novel antipsychotic use and its impact on the cost of care in a psychiatric hospital. ACCP Spring Practice and Research Forum. Monterey, CA 2006.
40. Chew ML, Pollock BG, Coley K, Marder SR, Miller D, Bies RR. Population Pharmacokinetic model of Quetiapine using highly sparse data from the CATIE study. Biological Psychiatry 2006;59(8 Suppl S):74S-74S,237.
41. Bigos K, Pollock BG, Coley KC, Marder SR, Miller D, Bies RR. Sources of variability in olanzapine exposure from the CATIE-AD Study. Biological Psychiatry 2006;59(8 Suppl S):140S-140-S, 455.
42. Feng Y, Pollock BG, Coley K, Marder SR, Miller D, Bies RR. Assessing sources of variability in risperidone pharmacokinetics: a population analysis of risperidone using highly sparse sampling measurements form the CATIE study. Biological Psychiatry 2006; 59 (8 Suppl S):230S-230S, 753.
43. Angalakuditi M, Coley K. Association between in-hospital falls, comorbidities, and drug use in adult chronic kidney disease patients: A case-control study. Value in Health 2006;(3):A95.
44. Scipio T, Coley KC, Fabian T, Lenze E. Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients. ACCP Annual Meeting, St. Louis, MO 2006.
45. Bollinger J, Coley K, Saul M, Rea RS. Outcomes in patients treated with recombinant human activated protein C (rhAPC) at an academic medical center versus the ENHANCE US Trial. SCCM Annual Congress, Orlando, FL 2007.
46. Coley KC, Fabian T, Scipio T, Kim E, Kim M, Ammerman D, Ganguli R. Predictors of aripiprazole treatment success in psychiatric inpatients. NCDEU. Boca Raton, FL. 2007.
47. Meyer S, Donegan T, Yaramus M, Coley K, Kane-Gill S, Connor S, et al. Public health: Outcome, definition, gap analysis, and new initiatives. AACP Annual Meeting. Lake Buena Vista, FL. 2007.
48. Jin Y, Pollock BG, Coley K, Miller D, Marder S, Kirshner M, Bies RR. Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: Impact of race, smoking, and concomitant medications. AAPS Annual Meeting. San Diego, CA 2007.
49. Palkovic LB, Sokos DR, Coley KC. Evaluation of clinical characteristics as predictors for the inappropriate prescribing of acid suppressive therapy in internal medicine inpatients. ACCP Annual Meeting. Denver, CO 2007.
50. Coley KC, Fabian T, Kim E, Ammerman D, Kim M, Whitehead R, Ganguli R. Predictors of aripiprazole success in inpatients with schizoprenia. Institute on Psychiatric Services Annual Meeting. New Orleans, LA 2007.
51. Angalakuditi M, Coley KC, Krenzelok E. Evaluation of adult acetaminophen exposures reported to a regional poison control center. ISPOR Annual Meeting. Toronto, Canada 2008.
52. Bies RR, Florian JA, Pollock BG, Bigos K, Chew M, Jin Y, Feng Y, Coley K, Schneider L, Muldoon M, Manuck S, Sale ME. A comparison of a genetic algorithm based automated search algorithm to standard stepwise approach for population pharmacokinetics using NONMEM. Population Approach Group Europe Meeting. Marseille, France. 2008.
53. Lavsa S, Fabian T, Shirley KL, Corman SC, Coley KC. Assessment of fall risk in psychiatric inpatients: A case-control study. 8th Annual WPIC Research Day. Pittsburgh, PA. 2008.
PRESENTATIONS
1. Therapeutic Uses of the Hematopoietic Colony Stimulating Factors. Philadelphia Veterans Administration Medical Center, September 1988.
2. The Role of Aerosolized Pentamidine in the Treatment of Pneumocystis carinii Pneumonia. Philadelphia College of Pharmacy and Science, November 1988.
3. Aerosolization Therapy and the Use of Aerosolized Pentamidine to Treat Pneumocystis carinii Pneumonia. Infectious Disease Conference. Mercy Catholic Medical Center, Upper Darby, PA. February 1989.
4. A Quality Assurance Program to Evaluate Responses Provided by a Hospital-Based Drug Information Center. Eastern States Conference for Pharmacy Residents and Preceptors. Boston, MA. 1990.
5. Aerosolized Pentamidine and Pneumocystis carinii Pneumonia Prophylaxis. University of Pittsburgh, School of Pharmacy, February 1990.
6. Finasteride for the management of benign prostatic hypertrophy. Internal Medicine Report. University of Pittsburgh Medical Center, 1992.
7. Ticlopidine versus aspirin for the prevention of stroke. Internal Medicine Report. University of Pittsburgh Medical Center, 1992.
8. Design and Implementation of a Multi-Hospital Staff Development Program in Drug Information at a University Medical Center. Platform presentation at the ASHP 27th Annual Midyear Clinical Meeting - SPG in Drug Information. Orlando, FL., 1992 Dec.
9. Update on female contraception. Continuing education for pharmacists. Pittsburgh, PA. 1992.
10. Critical evaluation of the professional literature. Drug Information Skills Update. Veterans Affairs Medical Center, Pittsburgh, PA 1992.
11. Communication of drug information. Drug Information Skills Update. Veterans Affairs Medical Center, Pittsburgh, PA 1992.
12. Computerized drug information databases. Drug Information Skills Update. Veterans Affairs Medical Center, Pittsburgh, PA 1992.
13. Common textbook references. Drug Information Skills Update. Veterans Affairs Medical Center, Pittsburgh, PA 1992.
14. Systematic search for drug information. Drug Information Skills Update. Veterans Affairs Medical Center, Pittsburgh, PA 1992.
15. Pharmaceutical care and the formulary process. University of Pittsburgh Medical Center, Pittsburgh, PA 1993.
16. Counseling patients on contraception. Continuing education for pharmacists. York, PA. 1993.
17. New drugs of 1992: anti-infective and miscellaneous agents. The 1993 Winter Practice and Research Forum of the American College of Clinical Pharmacy. Ft. Lauderdale, FL. 1993.
18. New drugs of 1992: anti-infective and miscellaneous agents. University of Pittsburgh. Pittsburgh, PA. 1993.
19. Practical methods to improve your drug information skills. WPSHP Pharmacists Clinical Skills Seminar and Workshop. Pittsburgh, PA., 1993.
20. New Drugs of 1993: respiratory gastrointestinal and miscellaneous agents. ASHP 28th Annual Midyear Clinical Meeting. Atlanta, GA., 1993 Dec.
21. Presenting a professional seminar. University of Pittsburgh Medical Center. Pittsburgh, PA 1994.
22. Centers of education and research in therapeutics (CERT): improving therapeutic efficiency through education and research to improve outcomes. NCDEU 35th Annual Meeting. Orlando, FL., 1995 Jun.
23. Postmarketing surveillance and outcomes research using automated databases. University of Pittsburgh Medical Center. Pittsburgh, PA 1996.
24. Using automated medical records to conduct clinical outcomes research. University of Pittsburgh Medical Center. Pittsburgh, PA 1997 Jan.
25. Clinical outcomes educational initiatives: the role of clinical pharmacology. University of Pittsburgh Medical Center. Pittsburgh, PA 1997 Aug.
26. Changing physician prescribing behavior: the community-acquired pneumonia intervention trial. ASHP 32nd Annual Meeting. Baltimore, MD. 1998 Jun.
27. Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol. 1998 ACCP Annual Meeting, Cincinnati, OH. November 1998.
28. Drug Therapy Outcomes Research Utilizing a Health System Data Repository. Outcomes Research and Design Conference. Philadelphia, PA. March 23-24. 2000.
29. Conducting outcomes research using a medical record data repository. University of Pittsburgh, Pittsburgh, PA. 2002.
30. Prevalence and outcomes of anemia in an elderly population seeking medical care. Pan Anemia Investigators Meeting. Santa Monica, CA. 2003.
31. Conducting a research project – How do I get started? ASHP Midyear Clinical Meeting. Anaheim, CA. 2006.
32. Bridging the medication gap from hospital to home: development and analysis of a continuity of care record. ASHP Foundation. Bethesda, MD. 2007.
33. Developing a quality medication use evaluation program: getting it right. ASHP Midyear Clinical meeting. LasVegas, NV. 2007.
GRANTS AND OTHER PROPOSALS FUNDED OR PENDING
1. Development of a migraine quality of life and pharmacoeconomic protocol. Glaxo Inc., Co-Principal Investigator. 1993. $3,500.
2. Comparative drug monographs. Express Pharmacy Services Medical Advisory Board, Co-Developer. 1993-1994. $16,500.
3. Itraconazole for the prophylaxis and treatment of invasive aspergillosis: a retrospective analysis of the cumulative experience at the University of Pittsburgh Medical Center. Janssen Pharmaceutica. Co-Investigator. 1994. $7,150.
4. Analgesic effects of quinine. The Hawthorne Group. Co-investigator. 1997. $100,000.
5. Comparative effectiveness of olanzapine, risperidone, and perphenazine in a naturalistic setting. Eli Lilly and Company. Primary Investigator. 1999. $54,495.
6. Retrospective Evaluation of Unanticipated Admissions and Readmissions after Ambulatory Surgery. Searle Pharmaceuticals. Consulting Agreement. Project Director. 2000. $38,125.
7. Under-recognition of Panic Attack: Evaluating Patient Presentations and Resource Utilization. Primary Investigator. Pfizer, Inc. 2001. $79,750.
8. Systems Approach for Improving Region-Wide Patient Safety. Co-Investigator. AHRQ. 2001-2004. $5,800,000.
9. Costs and Outcomes in Patients with Chronic Renal Insufficiency, Congestive Heart Failure and Anemia. Primary Investigator. Amgen. 2001. $108,000.
10. Atypical Antipsychotics: Determinents of Concentration. NIMH. Co-Investigator. 2001-2005. $800,000.
11. Development of a Chronic Renal Insufficiency Longitudinal Database. Amgen. Primary Investigator. 2001. $120,000.
12. Development of a Center for Pharmacoinformatics and Outcomes Research. Pharmacia and Upjohn. Co-Developer. 2001. $100,000.
13. Influence of Anemia on Health Resource Utilization in Patients with Chronic Diseases. Co-Investigator. Amgen, Inc. 2003-2004. $300,000.
14. Outcomes Research Fellowship. Co-Developer. Amgen, Inc. 2003-2005. $100,000.
15. Impact of Anemia on In-Hospital Falls. Primary Investigator. Amgen, Inc. 2003. $10,000.
16. Progression of Chronic Kideny Disease in a Health System Cohort. Co-Investigator. Amgen, Inc. $25,000.
17. Evaluation of Epoetin and Darbepoeitin Use and Associated Clinical Outcomes. Primary Investigator. Amgen, Inc. 2003. $50,000.
18. Prevalence and Outcomes of Anemia in the Elderly. Primary Investigator. Amgen, Inc. 2003. $75,000.
19. Impact of Anemia in Diabetic Patients with Chronic Kidney Disease. Primary Investigator. Amgen, Inc. 2003. $50,000.
20. Erythropoeitic Agents in the ICU Setting. Primary Investigator. Amgen, Inc. 2004. $28,750.
21. Aranesp Use in the Hospital Setting. Primary Investigator. Amgen, Inc. 2004. $24,750.
22. Predicting Aripiprazole Treatment Success in Patients Admitted to a Psychiatric Hospital. Primary Investigator. Bristol-Myers Squibb. 2006. $155,000.
23. Study of Medication Adherence and its Relationship to the Therapeutic Alliance. Co-Investigator. AstraZeneca. $50,000.
24. Bridging the Medication Use Gap from Hospital to Home: Development of a Continuity of Care Record. Primary Investigator. ASHP Foundation. 2007. $200,000.
25. Pharmacist Management of Polypharmacy: Reducing Fall Risk in Elderly Psychiatric Inpatients. Co-Investigator. Jewish Healthcare Foundation. 2008. $15,000.
GRANTS AND OTHER PROPOSALS NOT FUNDED
1. General Clinical Research Center - Center of Education and Research in Therapeutics, Supplement. NIH. Co-Investigator. 1996. $656,462.
2. A cost-effectiveness analysis of risperidone. American College of Clinical Pharmacy. Primary Investigator. 1996. $9,991.
3. Integrating automated and clinical adverse drug event research at the University of Pittsburgh Medical Center. The U.S. Food and Drug Administration. Co-Investigator. 1997. $1,018,490.
4. Efficiency of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, haloperidol and perphenazine. UPMC CMRF. Primary Investigator. 1998. $17,795.
5. Concurrent pharmacoepidemiologic profile of quetiapine fumarate at a university teaching hospital. Zeneca Pharmaceuticals. Primary Investigator. 1998. $23,000.
6. Evaluation of the outcomes of hemodialysis patients receiving amphotericin B lipid complex. The Liposome Company. Primary Investigator. 1998. $10,000.
7. UPMC-HS Center for Education and Research in Therapeutics for Optimal Use of Drugs in Hospitalized Patients. AHCPR. 1999. $2,886,780.
8. Fellowship in Outcomes Research. Fellowship Director. PhRMA Foundation. 2006. $80,000.
9. Development and Validation of a Self-Efficacy Questionnaire for Medication Management. Astra Zeneca. 2007. $50,000.